A phase II study of an investigational tetravalent influenza vaccine formulation combining MF59^®

References

• Belshe RB. Implications of the emergence of a novel H1 influenza virus. N Engl J Med 2009; 360:2667 - 8; http://dx.doi.org/10.1056/NEJMe0903995; PMID: 19423870
   PubMed Web of Science ®Google Scholar
• Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, Zaki SR, Hayden FG, Hui DS, Kettner JD, et al, Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010; 362:1708 - 19; http://dx.doi.org/10.1056/NEJMra1000449; PMID: 20445182
   PubMed Web of Science ®Google Scholar
• World Health Organization. Influenza. Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO. 29 August 2013: http://www.who.int/influenza/human_animal_interface/EN_GIP_20130829CumulativeNumberH5N1cases.pdf.
   Google Scholar
• Neumann G, Chen H, Gao GF, Shu Y, Kawaoka Y. H5N1 influenza viruses: outbreaks and biological properties. Cell Res 2010; 20:51 - 61; http://dx.doi.org/10.1038/cr.2009.124; PMID: 19884910
   PubMed Web of Science ®Google Scholar
• Russell CA, Fonville JM, Brown AE, Burke DF, Smith DL, James SL, Herfst S, van Boheemen S, Linster M, Schrauwen EJ, et al. The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science 2012; 336:1541 - 7; http://dx.doi.org/10.1126/science.1222526; PMID: 22723414
   PubMed Web of Science ®Google Scholar
• Jennings LC, Monto AS, Chan PK, Szucs TD, Nicholson KG. Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans. Lancet Infect Dis 2008; 8:650 - 8; http://dx.doi.org/10.1016/S1473-3099(08)70232-9; PMID: 18922487
   PubMed Web of Science ®Google Scholar
• Rebmann T, Zelicoff A. Vaccination against influenza: role and limitations in pandemic intervention plans. Expert Rev Vaccines 2012; 11:1009 - 19; http://dx.doi.org/10.1586/erv.12.63; PMID: 23002981
   PubMed Web of Science ®Google Scholar
• Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 2006; 354:1343 - 51; http://dx.doi.org/10.1056/NEJMoa055778; PMID: 16571878
   PubMed Web of Science ®Google Scholar
• Banzhoff A, Gasparini R, Laghi-Pasini F, Staniscia T, Durando P, Montomoli E, Capecchi PL, di Giovanni P, Sticchi L, Gentile C, et al. MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults. PLoS One 2009; 4:e4384; http://dx.doi.org/10.1371/journal.pone.0004384; PMID: 19197383
   PubMed Web of Science ®Google Scholar
• Leroux-Roels I, Borkowski A, Vanwolleghem T, Dramé M, Clement F, Hons E, Devaster JM, Leroux-Roels G. Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Lancet 2007; 370:580 - 9; http://dx.doi.org/10.1016/S0140-6736(07)61297-5; PMID: 17707753
   PubMed Web of Science ®Google Scholar
• Nicholson KG, Colegate AE, Podda A, Stephenson I, Wood J, Ypma E, Zambon MC. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. Lancet 2001; 357:1937 - 43; http://dx.doi.org/10.1016/S0140-6736(00)05066-2; PMID: 11425416
   PubMed Web of Science ®Google Scholar
• Stephenson I, Nicholson KG, Colegate A, Podda A, Wood J, Ypma E, Zambon M. Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population. Vaccine 2003; 21:1687 - 93; http://dx.doi.org/10.1016/S0264-410X(02)00632-1; PMID: 12639491
   PubMed Web of Science ®Google Scholar
• Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, Munster VJ, Sorrell EM, Bestebroer TM, Burke DF, Smith DJ, et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 2012; 336:1534 - 41; http://dx.doi.org/10.1126/science.1213362; PMID: 22723413
   PubMed Web of Science ®Google Scholar
• Kelly H, Barr I. Large trials confirm immunogenicity of H1N1 vaccines. Lancet 2010; 375:6 - 9; http://dx.doi.org/10.1016/S0140-6736(09)62132-2; PMID: 20018366
   PubMed Web of Science ®Google Scholar
• Manzoli L, De Vito C, Salanti G, D’Addario M, Villari P, Ioannidis JP. Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines. PLoS One 2011; 6:e24384; http://dx.doi.org/10.1371/journal.pone.0024384; PMID: 21915319
   PubMed Web of Science ®Google Scholar
• Fragapane E, Gasparini R, Schioppa F, Laghi-Pasini F, Montomoli E, Banzhoff A. A heterologous MF59-adjuvanted H5N1 prepandemic influenza booster vaccine induces a robust, cross-reactive immune response in adults and the elderly. Clin Vaccine Immunol 2010; 17:1817 - 9; http://dx.doi.org/10.1128/CVI.00461-09; PMID: 20810680
   PubMed Web of Science ®Google Scholar
• Khurana S, Chearwae W, Castellino F, Manischewitz J, King LR, Honorkiewicz A, Rock MT, Edwards KM, Del Giudice G, Rappuoli R, et al. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus. Sci Transl Med 2010; 2:ra5; http://dx.doi.org/10.1126/scitranslmed.3000624; PMID: 20371470
   PubMed Web of Science ®Google Scholar
• Khurana S, Verma N, Yewdell JW, Hilbert AK, Castellino F, Lattanzi M, Del Giudice G, Rappuoli R, Golding H. MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines. Sci Transl Med 2011; 3:85ra48; http://dx.doi.org/10.1126/scitranslmed.3002336; PMID: 21632986
   PubMed Web of Science ®Google Scholar
• Gasparini R, Schioppa F, Lattanzi M, Barone M, Casula D, Pellegrini M, Veitch K, Gaitatzis N. Impact of prior or concomitant seasonal influenza vaccination on MF59-adjuvanted H1N1v vaccine (Focetria) in adult and elderly subjects. Int J Clin Pract 2010; 64:432 - 8; http://dx.doi.org/10.1111/j.1742-1241.2009.02309.x; PMID: 20039974
   PubMed Web of Science ®Google Scholar
• Vajo Z, Tamas F, Sinka L, Jankovics I. Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial. Lancet 2010; 375:49 - 55; http://dx.doi.org/10.1016/S0140-6736(09)62039-0; PMID: 20018367
   PubMed Web of Science ®Google Scholar
• Lopez P, Caicedo Y, Sierra A, Tilman S, Banzhoff A, Clemens R. Combined, concurrent, and sequential administration of seasonal influenza and MF59-adjuvanted A/H5N1 vaccines: a phase II randomized, controlled trial of immunogenicity and safety in healthy adults. J Infect Dis 2011; 203:1719 - 28; http://dx.doi.org/10.1093/infdis/jir191; PMID: 21606530
   PubMed Web of Science ®Google Scholar
• Pellegrini M, Nicolay U, Lindert K, Groth N, Della Cioppa G. MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database. Vaccine 2009; 27:6959 - 65; http://dx.doi.org/10.1016/j.vaccine.2009.08.101; PMID: 19751689
   PubMed Web of Science ®Google Scholar
• Schultze V, D’Agosto V, Wack A, Novicki D, Zorn J, Hennig R. Safety of MF59 adjuvant. Vaccine 2008; 26:3209 - 22; http://dx.doi.org/10.1016/j.vaccine.2008.03.093; PMID: 18462843
   PubMed Web of Science ®Google Scholar
• Crucitti A, Tsai TF. Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy: a six-month update. Scand J Infect Dis 2011; 43:993; http://dx.doi.org/10.3109/00365548.2011.608714; PMID: 21851329
   PubMed Web of Science ®Google Scholar
• Tsai TF, Crucitti A, Nacci P, Nicolay U, Della Cioppa G, Ferguson J, Clemens R. Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy. Scand J Infect Dis 2011; 43:702 - 6; PMID: 21534891
   PubMed Web of Science ®Google Scholar
• Stöhr K. Vaccinate before the next pandemic?. Nature 2010; 465:161; http://dx.doi.org/10.1038/465161a; PMID: 20463719
   PubMed Web of Science ®Google Scholar
• Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC, Burke DS. Strategies for mitigating an influenza pandemic. Nature 2006; 442:448 - 52; http://dx.doi.org/10.1038/nature04795; PMID: 16642006
   PubMed Web of Science ®Google Scholar